Article Information
Published By
Online ISSN
History
- Received April 4, 2022
- Accepted June 28, 2022
- Published online July 28, 2022.
Article Versions
- You are currently viewing a previous version of this article (July 28, 2022 - 08:55).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Johannes A. Kroes1,
- Aruna T. Bansal2,
- Emmanuelle Berret3,
- Nils Christian4,
- Andreas Kremer4,
- Anna Alloni5,
- Matteo Gabetta5,
- Chris Marshall6,
- Scott Wagers7,
- Ratko Djukanovic8,
- Celeste Porsbjerg9,
- Dominique Hamerlijnck10,
- Olivia Fulton10,
- Anneke ten Brinke11,
- Elisabeth H. Bel12⇑ and
- Jacob K. Sont13
- 1Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
- 2Acclarogen Ltd, Cambridge, UK
- 3European Respiratory Society, Lausanne, Switzerland
- 4ITTM S.A., Esch-sur-Alzette, Luxembourg
- 5Biomeris SRL, Pavia, Italy
- 6Metaseq Ltd
- 7BIOSCI Consulting, Maasmechelen, Belgium
- 8NIHR Southampton Respiratory Biomedical Research Unit, Faculty of Medicine, University Southampton, Southampton, UK
- 9Dept of Pulmonology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
- 10Patient Advisory Group, European Lung Foundation (ELF), Sheffield, UK
- 11Department of Pulmonology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
- 12Amsterdam Medical Centers, Location AMC, University of Amsterdam, The Netherlands
- 13Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands
- Corresponding author: Elisabeth Bel (e.h.bel{at}amsterdamumc.nl)
Funding
European Respiratory Society
SHARP CRCGlaxoSmithKline
ERS CRC SHARPTeva Pharmaceutical Industries
ERS CRC SHARPNovartis
ERS CRC SHARPSanofi
ERS CRC SHARPChiesi Farmaceutici
ERS CRC SHARP